Follow
Clemens Möller
Clemens Möller
Professor of Biophysics, Albstadt-Sigmaringen University
Verified email at hs-albsig.de - Homepage
Title
Cited by
Cited by
Year
Tapping-mode atomic force microscopy produces faithful high-resolution images of protein surfaces
C Möller, M Allen, V Elings, A Engel, DJ Müller
Biophysical journal 77 (2), 1150-1158, 1999
3731999
From images to interactions: high-resolution phase imaging in tapping-mode atomic force microscopy
M Stark, C Möller, DJ Müller, R Guckenberger
Biophysical Journal 80 (6), 3009-3018, 2001
2252001
Stability of bacteriorhodopsin α-helices and loops analyzed by single-molecule force spectroscopy
DJ Müller, M Kessler, F Oesterhelt, C Möller, D Oesterhelt, H Gaub
Biophysical journal 83 (6), 3578-3588, 2002
2092002
Atomic force microscopy of native purple membrane
DJ Müller, JB Heymann, F Oesterhelt, C Möller, H Gaub, G Büldt, A Engel
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1460 (1), 27-38, 2000
1662000
Early identification of hERG liability in drug discovery programs by automated patch clamp
T Danker, C Möller
Frontiers in pharmacology 5, 87849, 2014
1092014
Single proteins observed by atomic force microscopy
S Scheuring, D Fotiadis, C Möller, SA Müller, A Engel, DJ Müller
Single Molecules 2 (2), 59-67, 2001
922001
Determining molecular forces that stabilize human aquaporin-1
C Möller, D Fotiadis, K Suda, A Engel, M Kessler, DJ Müller
Journal of structural biology 142 (3), 369-378, 2003
862003
Novel screening techniques for ion channel targeting drugs
A Obergrussberger, S Stölzle-Feix, N Becker, A Brüggemann, N Fertig, ...
Channels 9 (6), 367-375, 2015
482015
Effects of estradiol on cardiac ion channel currents
C Möller, R Netzer
European journal of pharmacology 532 (1-2), 44-49, 2006
482006
Reversible loss of crystallinity on photobleaching purple membrane in the presence of hydroxylamine
C Möller, G Büldt, NA Dencher, A Engel, DJ Müller
Journal of molecular biology 301 (4), 869-879, 2000
472000
Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons
D Loser, MG Hinojosa, J Blum, J Schaefer, M Brüll, Y Johansson, I Suciu, ...
Archives of Toxicology 95, 2081-2107, 2021
462021
Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling
D Loser, K Grillberger, MG Hinojosa, J Blum, Y Haufe, T Danker, ...
Archives of toxicology 95, 3695-3716, 2021
422021
Impact of new technologies for cellular screening along the drug value chain
C Möller, M Slack
Drug discovery today 15 (9-10), 384-390, 2010
402010
Automated electrophysiology makes the pace for cardiac ion channel safety screening
C Möller, H Witchel
Frontiers in Pharmacology 2, 73, 2011
392011
Automated planar patch-clamp
CJ Milligan, C Möller
Ion Channels: Methods and Protocols, 171-187, 2013
352013
Novel 6, 7, 8, 9-tetrahydro-5H-1, 4, 7, 10a-tetraaza-cyclohepta [f] indene analogues as potent and selective 5-HT2C agonists for the treatment of metabolic disorders
H Tye, SG Mueller, J Prestle, S Scheuerer, M Schindler, B Nosse, ...
Bioorganic & medicinal chemistry letters 21 (1), 34-37, 2011
292011
Effects of common antitussive drugs on the hERG potassium channel current
H Deisemann, N Ahrens, I Schlobohm, C Kirchhoff, R Netzer, C Möller
Journal of cardiovascular pharmacology 52 (6), 494-499, 2008
272008
Sampling effects influence heights measured with atomic force microscopy
JB Heymann, C Möller, DJ Müller
Journal of microscopy 207 (1), 43-51, 2002
212002
1, 4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability
D Riether, L Wu, PF Cirillo, A Berry, ER Walker, M Ermann, ...
Bioorganic & medicinal chemistry letters 21 (7), 2011
202011
Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology
C Möller
Expert Review of Clinical Pharmacology 3 (3), 321-329, 2010
182010
The system can't perform the operation now. Try again later.
Articles 1–20